Info: Read More
  • 中药标准品生产商,产品定制服务
  • 田蓟苷


    产品编号 CFN92764
    CAS编号 4291-60-5
    分子式 = 分子量 C22H22O10 = 446.1
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Flavonoids
    植物来源 The leaves of Tilia japonica.
    产品名称 产品编号 CAS编号 包装 QQ客服
    田蓟苷 CFN92764 4291-60-5 10mg QQ客服:2932563308
    田蓟苷 CFN92764 4291-60-5 20mg QQ客服:2932563308
    田蓟苷 CFN92764 4291-60-5 50mg QQ客服:2932563308
    田蓟苷 CFN92764 4291-60-5 100mg QQ客服:2932563308
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: 或

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.

    PMID: 30417089
  • Mahatma Gandhi University (India)
  • Universitas Airlangga (Indonesia)
  • Sapienza University of Rome (Italy)
  • University of Liège (Belgium)
  • University of Padjajaran (Indonesia)
  • Wroclaw Medical University (Poland)
  • Northeast Normal University Changchun (China)
  • Sri Ramachandra University (India)
  • University of Illinois at Chicago (USA)
  • Instytut Nawozów Sztucznych w Pu?awach (Poland)
  • Shanghai Institute of Organic Chemistry (China)
  • University of the Basque Country (Spain)
  • Celltrion Chemical Research Institute (Korea)
  • Macau University of Science and Technology (China)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Biochem Biophys Res Commun.2017, 494(3-4):587-593
  • J Pharm Biomed Anal2016, 118:183-194
  • J Liq Chromatogr R T2018, 41(12):761-769
  • Oncotarget.2017, 8(53):90925-90947
  • Br J Pharmacol.2020, 10.1111
  • Nat Prod Commun.2018, 10.1177
  • Int J Pharmacol2020, 16:1-9
  • Antioxidants (Basel).2021, 10(9):1435.
  • Oncol Rep.2019, 41(4):2453-2463
  • Biochem Biophys Res Commun.2017, 482(4):1095-1101
  • Front Microbiol.2021, 12:736780.
  • Biosci. Rep.2020, 10.1024
  • Biomedicines.2021, 9(8):954.
  • Pharmacol Rep.2020, 72(2):472-480.
  • Molecules.2015, 20(10):19172-88
  • Evid Based Complement Alternat Med.2020, 2020:8582318.
  • World J Mens Health.2019, 10.5534
  • Front Aging Neurosci.2019, 11:230
  • J Food Biochem.2020, 44(6):e13198.
  • Pharmaceuticals (Basel).2021, 14(8):742.
  • Antioxidants.2022, 11(3):592.
  • Acta horticulturae2017, 1158:257-268
  • Drug Des Devel Ther.2020, 14:5189-5204.
  • ...
  • 生物活性
    Description: Tilianin has anti-inflammatory, antiatherogenic, antihypertensive and vasorelaxant activities, mediates relaxation and antihypertension mainly by an endothelium-dependent manner, probably due to NO release, and also through an endothelium-independent pathway by opening K+ channels. Tilianin inhibits the tumor necrotic factor-K (TNF-K)-induced expression of VCAM-1 by 74% and reduces TNF-K-induced activation of nuclear factor-UB in cultured human umbilical vein endothelial cells (HUVECs).
    Targets: 5-HT Receptor | GABA Receptor | ATPase | NO | NOS | Caspase | Bcl-2/Bax | Potassium Channel | P-gp
    In vivo:
    Mol Med Rep. 2015 Mar;11(3):2227-33.
    Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury.[Pubmed: 25405380 ]
    Tilianin, the main effective flavonoid monomer enriched from Dracocephalum moldavuca L., has been shown to have cardioprotective effects. However, the mechanism of Tilianin cardioprotection remains largely unknown. The present study aimed to investigate the effects of Tilianin preconditioning on myocardial ischemia/reperfusion injury and to analyze the possible mechanism of action.
    A total of 48 male Sprague Dawley rats were randomized into sham, model myocardial ischemia/reperfusion injury (MI/RI), propranolol hydrochloride positive control, and high‑, medium‑ and low‑dose Tilianin groups (n=8 each). The results showed that Tilianin preconditioning significantly increased ATPase activity (P<0.01 and P<0.05) as compared with the model group. With regards to the regulation of endothelial function, significant decreases (P<0.01 and P<0.05) were detected in the serum NO levels and myocardial NOS activity when Tilianin was administered to MI/RI rats, as compared with the model group, . In addition, the Tilianin drug groups exhibited dose‑dependent reductions in the serum levels of endothelin 1 and thromboxane B2, and increases in the serum levels of calcitonin gene‑related peptide and 6‑keto prostaglandin F1a as compared with the model group (P<0.01 and P<0.05). Notably, the administration of Tilianin significantly inhibited apoptosis, as evidenced by an increase in Bcl‑2 expression, and reductions in Bax and caspase‑3 mRNA expression levels (P<0.01 and P<0.05).
    These data indicate that pretreatment with Tilianin exerts potent cardioprotective effects in rats with MI/RI. The anti‑MI/RI effects comprised relieving calcium overload, correction of energy metabolism, improvement of endothelial function and inhibiting cell apoptosis.
    Biochem Pharmacol. 2009 Jul 1;78(1):54-61.
    Antihypertensive and vasorelaxant effects of tilianin isolated from Agastache mexicana are mediated by NO/cGMP pathway and potassium channel opening.[Pubmed: 19447223]
    Current investigation was undertaken to elucidate the mode of action of Tilianin, isolated from Agastache mexicana, as a vasorelaxant agent on in vitro functional rat thoracic aorta test and to investigate the in vivo antihypertensive effect on spontaneously hypertensive rats (SHR).
    Tilianin (0.002-933 microM) induced significant relaxation in a concentration- and endothelium-dependent and -independent manners in aortic rings pre-contracted with noradrenaline (NA, 0.1 microM), and serotonin (5-HT, 100 microM). Furthermore, Tilianin (130 microM) provoked a significant displacement to the left in the relaxation curve induced by sodium nitroprusside (SNP; 0.32 nM to 0.1 microM). Moreover, Tilianin induced significant in vitro NO overproduction (1.49 +/- 0.86 microM of nitrites/g of tissue) in rat aorta compared with vehicle (p < 0.05). In addition, pre-treatment with tetraethylammonium (TEA, 5 mM) and 2-aminopyridine (2-AP, 0.1 microM) shifted to the right the relaxant curve induced by Tilianin (p < 0.05). Finally, a single oral administration of Tilianin (50 mg/kg) exhibited a significant decrease in systolic and diastolic blood pressures (p < 0.05) in SHR model.
    Results indicate that Tilianin mediates relaxation mainly by an endothelium-dependent manner,probably due to NO release, and also through an endothelium-independent pathway by opening K+ channels, both causing the antihypertensive effect.
    Zhongguo Zhong Yao Za Zhi. 2013 Apr;38(7):1079-82.
    Study on intestinal absorption of tilianin in rats of single-pass perfusion model.[Pubmed: 23847962]
    To study the intestinal absorption mechanism of Tilianin in rats.
    The single-pass perfusion model was established in rats. The concentrations of Tilianin with in situ intestinal perfusion were determined by HPLC. The impact factors, such as verapamil, reserpine, phloridzin and rifampicin, on Ka and Papp of Tilianin in rat jejunum were investigated. Compared with the control group, Ka and Papp in rat jejunum were significantly higher after being added with verapamil and reserpine (P < 0.05). Papp of Tilianin in rat jejunum was significantly lower after being added with phloridzin (P < 0.05). Compared with the control group, both Ka and Papp of Tilianin in rat jejunum were not significantly higher after being added with rifampicin.
    Tilianin is the substrate of P-gp, BCRP and SGLT1. The effluent effect of P-gp and BCRP is the main mechanism of Tilianin in intestinal absorption, indicating that Tilianin can realize intestinal absorption and transport by relying on SGLT1. Tilianin is not the substrate of bile salt transporter protein.
    J Environ Pathol Toxicol Oncol . 2020;39(4):335-344.
    Role of Tilianin against Acute Lung Injury in In Vitro LPS-Induced Alveolar Macrophage Cells and an In Vivo C57BL/6 Mice Model[Pubmed: 33389905]
    Abstract Acute lung injury (ALI) is a disorder of pulmonary tissue caused by prolonged inflammation and uncontrolled oxidative stress. Tilianin is a natural polyphenol, acknowledged for its anti-inflammatory and antioxidant activities. The goal of this work was to explore the effect of tilianin in an LPS-challenged ALI model. The mechanistic investigation was carried out using both in vitro and in vivo experiments. The RAW264.7 macrophage cell and C57BL/6 mice were treated with Tilianin (10 and 20 μM) and then induced with LPS (1 μg/mL) overnight. The C57BL/6 mouse was administered LPS intratracheally (2 mg/kg) to induce ALI prior to tilianin intraperitoneal treatment (10 mg/kg). In vitro, the results showed that Tilianin reduced secretion of LPS-induced proinflammatory cytokine. In vivo, prophylactic treatment with tilianin attenuated infiltration of macrophages and histopathological changes and improved inflammation as shown by a marked reduction in inflammatory mediators found in bronchoalveolar lavage fluid (BALF). Furthermore, tilianin effectively suppressed MDA levels and GSH and SOD in ALI were increased. Collectively, these findings suggest that tilianin is a potential agent for ameliorating LPS-induced ALI.
    Biomed Chromatogr . 2018 Apr;32(4).
    Simultaneous determination of tilianin and its metabolites in mice using ultra-high-performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study[Pubmed: 29144552]
    Abstract Tilianin is an active flavonoid glycoside found in many medical plants. Data are lacking regarding its pharmacokinetics and disposition in vivo. The objective of this study was to develop a sensitive, reliable and validated ultra-high-performance liquid chromatography with tandem mass spectrometry (UHPLC-MS/MS) method to simultaneously quantify tilianin and its main metabolites and to determine its pharmacokinetics in wild-type and breast cancer resistance protein knockout (Bcrp1-/-) FVB mice. Chromatographic separation was accomplished on a C18 column by utilizing acetonitrile and 0.5 mm ammonium acetate as the mobile phase. Mass spectrometric detection was performed using electrospray ionization in both positive and negative modes. The results showed that the precision, accuracy and recovery, as well as the stability of tilianin and its metabolites in mouse plasma, were all within acceptable limits. Acacetin-7-glucuronide and acacetin-7-sulfate were the major metabolites of tilianin in mouse plasma. Moreover, systemic exposure of acacetin-7-sulfate was significantly higher in Bcrp1 (-/-) FVB mice compared with wild-type FVB mice. In conclusion, the fully validated UHPLC-MS/MS method was sensitive, reliable, and was successfully applied to assess the pharmacokinetics of tilianin in wild-type and Bcrp1 (-/-) FVB mice. Breast cancer resistance protein had a significant impact on the elimination of the sulfated metabolite of tilianin in vivo. Keywords: BCRP; UHPLC-MS/MS; pharmacokinetics; tilianin.
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.2416 mL 11.2082 mL 22.4165 mL 44.833 mL 56.0412 mL
    5 mM 0.4483 mL 2.2416 mL 4.4833 mL 8.9666 mL 11.2082 mL
    10 mM 0.2242 mL 1.1208 mL 2.2416 mL 4.4833 mL 5.6041 mL
    50 mM 0.0448 mL 0.2242 mL 0.4483 mL 0.8967 mL 1.1208 mL
    100 mM 0.0224 mL 0.1121 mL 0.2242 mL 0.4483 mL 0.5604 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    异野漆树苷; Isorhoifolin CFN98927 552-57-8 C27H30O14 = 578.5 5mg QQ客服:215959384
    女贞苷; Ligustroflavone CFN90224 260413-62-5 C33H40O18 = 724.67 20mg QQ客服:1413575084
    芹菜素-7-0-(2G-鼠李糖)龙胆糖苷; Apigenin 7-O-(2G-rhamnosyl)gentiobioside CFN90671 174284-20-9 C33H40O19 = 740.67 20mg QQ客服:1413575084
    Anisofolin A; Anisofolin A CFN97327 83529-71-9 C39H32O14 = 724.7 5mg QQ客服:2159513211
    野黄芩素-7-O-葡萄糖苷; Scutellarein-7-O-glucoside CFN95082 26046-94-6 C21H20O11 = 448.4 5mg QQ客服:1148253675
    野黄芩苷; Scutellarin CFN99112 27740-01-8 C21H18O12 = 462.37 20mg QQ客服:2932563308
    野黄芩苷甲酯; Scutellarin methylester CFN90695 119262-68-9 C22H20O12 = 476.39 20mg QQ客服:3257982914
    高车前苷; Homoplantaginin CFN90344 17680-84-1 C22H22O11 = 462.40 20mg QQ客服:2932563308
    高车前素 7-O-新橙皮糖苷; Hispidulin 7-O-neohesperidoside CFN90892 156186-00-4 C28H32O15 = 608.6 5mg QQ客服:2932563308
    Comanthosid B; Comanthosid B CFN91174 70938-60-2 C23H22O12 = 490.4 5mg QQ客服:1148253675





    在线QQ: 1413575084


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产